Advances in Stem Cell Research and Regenerative Medicine

The process by which samples of bodily fluid or tissue are collected for research use to improve our understanding of health and disease. There are various styles to save tissue and DNA samples that are well tested and frequently used including freezing, drying and storage in ethanol or buffer. Bio banking could be a type of biorespository that stores biological samples. Bio banks can give experimenters access to data representing an outsized number of people.

Biomaterials is the field of study in which scientists engineer a substance to direct, through the use of living organisms, a therapeutic or diagnostic procedure. In BE, there are professors studying biomaterials to manipulate immune cells, to deliver drugs in novel ways, and to create complex tissue microstructures.

Our conference is focusing on latest advancement and discoveries in the field of stem cell and regenerative medicine. Stem cells are special human cells that are able to develop into many different cell types. This can range from muscle cells to brain cells.

9. 
   In our conference we will discuss the latest and advance techniques in steam cell.

• 
  Immunomagnetic cell separation.


• 
  Fluorescence-activated cell sorting (FACS)


• 
  Density gradient centrifugation.


• 
  Immunodensity cell isolation.


• 
  Microfluidic cell sortin

As the population ages, there is an increasing need for organ and tissue replacement to cope with the deterioration and disease of cardiovascular, gastrointestinal, kidney, and musculoskeletal organs. Transplantation of live and dead donor organs cannot currently meet this need. Regenerative medicine is an interdisciplinary field that incorporates stem cell biology, immunology, materials science, engineering, medicine, and surgery to develop solutions that can enhance or replace the regenerative capacity of the body's own tissues. With such a wide range of disciplines, it is important for different stakeholders to understand where the overall picture of the process of developing and clinically using regenerative medicine products fits. It also discusses recent surgical applications in regenerative medicine.

The neonatal stem cells are collected from placental tissues and cord blood. The stem cells are made up of mesenchyme and hematopoietic cells, which are multipotent cells. Fetal and Neonatal Stem Cells can be used to test a drug's ability to damage genetic material or to test the effects of specific viral (or other types) of infection.

Cancer stem cells (CSCs) are a subpopulation of tumour cells that can drive tumour initiation and can cause relapses. At the time point of tumour initiation, CSCs originate from either differentiated cells or adult tissue resident stem cells.

Engineering, manufacturing, art, education, and medicine are just a few of the fields where three-dimensional (3D) printing is driving substantial changes. Biocompatible materials, cells, and supporting components can now be 3D printed into complex 3D functioning living tissues, thanks to recent advancements. To meet the demand for transplantable tissues and organs, 3D bio printing is being used in regenerative medicine. 3D bio printing has more complexities than non-biological printing, such as material selection, cell kinds, growth and differentiation variables, and technical obstacles associated to living cell sensitivities and tissue assembly. Engineering, biomaterials science, cell biology, physics, and medicine must all work together to solve these problems. Bio printing in 3D has already been used to create and test new drugs.

 Bioinformatics frameworks developed in recent years that will facilitate analysis and promote the application of stem cells to medical research. The stem cell bioinformatics uses computational methods to explore the molecular mechanisms underpinning stem cells and will accelerate the application of these stem cells to regenerative medicine.

The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs. Artificial skin and cartilage are examples of engineered tissues that have been approved by the FDA; however, currently they have limited use in human patients. Tissue engineering is a new biotechnology which aims to generate autologous tissue graft with an engineering approach.

Regenerative medicine deals with the "process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function". Stem cell therapy is considered a safe and effective treatment option for many conditions, and many clinical trials have shown promising results. In our conference we will discuss newly discovered concepts in regenerative medicine and stem cell treatments.